Home / CDC37 Knockout Cell Lines

CDC37 Knockout Cell Lines

Gene: CDC37

Official Full Name: cell division cycle 37, HSP90 cochaperoneprovided by HGNC

Gene Summary: The protein encoded by this gene is highly similar to Cdc 37, a cell division cycle control protein of Sacchromyces cerevisiae. This protein is a molecular chaperone with specific function in cell signal transduction. It has been shown to form complex with Hsp90 and a variety of protein kinases including CDK4, CDK6, SRC, RAF-1, MOK, as well as eIF2 alpha kinases. It is thought to play a critical role in directing Hsp90 to its target kinases. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO01326 CDC37 Knockout cell line (HeLa) Human CDC37 1:3~1:6 Negative Online Inquiry

Background

CDC37 Gene Knockout Cell Lines are specialized cellular models engineered to lack the CDC37 gene, which encodes a co-chaperone of Hsp90, a critical molecular chaperone involved in protein folding and stability. By precision gene editing techniques, these cell lines facilitate comprehensive studies investigating the role of CDC37 in cellular processes, including signal transduction, cell cycle regulation, and disease mechanisms such as cancer.

The key function and mechanism of the CDC37 Gene Knockout Cell Lines lie in their ability to mimic the effects of loss-of-function mutations in the CDC37 gene. Researchers can observe how the absence of this gene alters cellular protein homeostasis, affects the stability of client proteins reliant on the Hsp90 chaperone complex, and leads to eventual phenotypic changes. This provides valuable insights into the pathways associated with CDC37, making these cell lines powerful tools for elucidating the underlying mechanisms of various diseases.

Scientifically, the importance of these cell lines extends to research and clinical applications, particularly in cancer biology, neurodegenerative diseases, and therapeutic development. They serve as an essential model for testing the efficacy of drugs targeting Hsp90-related pathways, which are promising in clinical settings for cancer therapy.

Unique selling points of CDC37 Gene Knockout Cell Lines include their high specificity and reproducibility, which offer a level of consistency not always found in other models, such as primary cells or tumor xenografts. Additionally, the precise gene knockout eliminates potential off-target effects, producing more reliable data crucial for downstream applications.

For researchers and clinicians, the value of utilizing CDC37 Gene Knockout Cell Lines cannot be overstated. They enable a deeper mechanistic understanding of essential cellular processes and can significantly expedite the drug discovery process in oncological research.

As a company dedicated to advancing molecular biology tools, we leverage cutting-edge techniques to provide high-quality biological products that empower researchers to make groundbreaking discoveries. Our expertise in gene editing ensures that each cell line is validated and characterized to meet the demanding standards of modern scientific research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.